US Stock MarketDetailed Quotes

Vor Biopharma (VOR)

Watchlist
  • 15.910
  • -0.560-3.40%
Close May 13 15:59 ET
862.10MMarket Cap-0.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vor Biopharma (VOR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.61%35.16M
206.67%371.64M
14.85%35.96M
-1.42%28.11M
844.67%274.28M
2.99%33.29M
-3.85%121.19M
11.33%31.31M
-19.26%28.51M
-9.76%29.04M
Selling and administrative expenses
166.54%17.57M
79.77%50.11M
181.23%16.77M
108.56%13.97M
77.27%12.79M
-17.67%6.59M
-12.12%27.88M
-17.49%5.96M
-13.15%6.7M
-12.87%7.21M
-General and administrative expense
166.54%17.57M
79.77%50.11M
181.23%16.77M
108.56%13.97M
77.27%12.79M
-17.67%6.59M
-12.12%27.88M
-17.49%5.96M
-13.15%6.7M
-12.87%7.21M
Research and development costs
-34.10%17.6M
244.58%321.53M
-24.29%19.19M
-35.18%14.14M
1,098.27%261.5M
9.78%26.7M
-1.07%93.31M
21.30%25.35M
-20.97%21.82M
-8.68%21.82M
Operating profit
-5.61%-35.16M
-206.67%-371.64M
-14.85%-35.96M
1.42%-28.11M
-844.67%-274.28M
-2.99%-33.29M
3.85%-121.19M
-11.33%-31.31M
19.26%-28.51M
9.76%-29.04M
Net non-operating interest income expense
388.82%3.94M
37.39%5.87M
366.61%2.8M
81.45%1.73M
-55.10%537K
-47.11%805K
-47.74%4.27M
-67.85%599K
-55.13%954K
-45.51%1.2M
Non-operating interest income
388.82%3.94M
37.39%5.87M
366.61%2.8M
81.45%1.73M
-55.10%537K
-47.11%805K
-47.74%4.27M
-67.85%599K
-55.13%954K
-45.51%1.2M
Other net income (expense)
-188.36M
-330.21M
1.76B
-786.31M
-1.3B
Gain on sale of security
---188.36M
---334.36M
--1.76B
---790.46M
---1.3B
----
----
----
----
----
Other non- operating income (expenses)
----
--4.15M
--2K
--4.15M
----
----
----
----
----
----
Income before tax
-575.94%-219.59M
-495.29%-695.98M
5,709.72%1.72B
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
Income tax
Net income
-575.94%-219.59M
-495.29%-695.98M
5,709.72%1.72B
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
Net income continuous Operations
-575.94%-219.59M
-495.29%-695.98M
5,709.72%1.72B
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
Minority interest income
Net income attributable to the parent company
-575.94%-219.59M
-495.29%-695.98M
5,709.72%1.72B
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-575.94%-219.59M
-495.29%-695.98M
5,709.72%1.72B
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
Basic earnings per share
1.92%-5.11
-107.17%-70.5
606.78%44.4951
-1,410.93%-121.63
-2,963.41%-251.2
42.11%-5.21
2.77%-34.03
-15.53%-8.78
17.86%-8.05
8.89%-8.2
Diluted earnings per share
1.92%-5.11
-107.17%-70.5
606.78%44.4951
-1,410.93%-121.63
-2,963.41%-251.2
42.11%-5.21
2.77%-34.03
-15.53%-8.78
17.86%-8.05
8.89%-8.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.61%35.16M206.67%371.64M14.85%35.96M-1.42%28.11M844.67%274.28M2.99%33.29M-3.85%121.19M11.33%31.31M-19.26%28.51M-9.76%29.04M
Selling and administrative expenses 166.54%17.57M79.77%50.11M181.23%16.77M108.56%13.97M77.27%12.79M-17.67%6.59M-12.12%27.88M-17.49%5.96M-13.15%6.7M-12.87%7.21M
-General and administrative expense 166.54%17.57M79.77%50.11M181.23%16.77M108.56%13.97M77.27%12.79M-17.67%6.59M-12.12%27.88M-17.49%5.96M-13.15%6.7M-12.87%7.21M
Research and development costs -34.10%17.6M244.58%321.53M-24.29%19.19M-35.18%14.14M1,098.27%261.5M9.78%26.7M-1.07%93.31M21.30%25.35M-20.97%21.82M-8.68%21.82M
Operating profit -5.61%-35.16M-206.67%-371.64M-14.85%-35.96M1.42%-28.11M-844.67%-274.28M-2.99%-33.29M3.85%-121.19M-11.33%-31.31M19.26%-28.51M9.76%-29.04M
Net non-operating interest income expense 388.82%3.94M37.39%5.87M366.61%2.8M81.45%1.73M-55.10%537K-47.11%805K-47.74%4.27M-67.85%599K-55.13%954K-45.51%1.2M
Non-operating interest income 388.82%3.94M37.39%5.87M366.61%2.8M81.45%1.73M-55.10%537K-47.11%805K-47.74%4.27M-67.85%599K-55.13%954K-45.51%1.2M
Other net income (expense) -188.36M-330.21M1.76B-786.31M-1.3B
Gain on sale of security ---188.36M---334.36M--1.76B---790.46M---1.3B--------------------
Other non- operating income (expenses) ------4.15M--2K--4.15M------------------------
Income before tax -575.94%-219.59M-495.29%-695.98M5,709.72%1.72B-2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M
Income tax
Net income -575.94%-219.59M-495.29%-695.98M5,709.72%1.72B-2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M
Net income continuous Operations -575.94%-219.59M-495.29%-695.98M5,709.72%1.72B-2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M
Minority interest income
Net income attributable to the parent company -575.94%-219.59M-495.29%-695.98M5,709.72%1.72B-2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -575.94%-219.59M-495.29%-695.98M5,709.72%1.72B-2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M
Basic earnings per share 1.92%-5.11-107.17%-70.5606.78%44.4951-1,410.93%-121.63-2,963.41%-251.242.11%-5.212.77%-34.03-15.53%-8.7817.86%-8.058.89%-8.2
Diluted earnings per share 1.92%-5.11-107.17%-70.5606.78%44.4951-1,410.93%-121.63-2,963.41%-251.242.11%-5.212.77%-34.03-15.53%-8.7817.86%-8.058.89%-8.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -